Search

everythinglearnresearchcommunity

for

Search:↓

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Amphetamines may not directly cause hair loss, as the type of thinning seen with their use differs from severe alopecia.

Metronidazole can cause lung disease.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Amphetamine use may not cause hair loss, "geezer" traits are normal aging, not all educated older people are stereotypes, and metronidazole can rarely cause lung disease.

Amphetamines may not directly cause hair loss.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Some medications can cause hair loss, and it's important to track when the hair loss starts after taking a new medication.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Low iron levels may be linked to some types of hair loss in women.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

A new gene, JMJD1C, may affect testosterone levels in men.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

People with hair loss, especially those with certain types, have lower zinc levels, and zinc supplements might help.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.